Liminal Biosciences Inc (DELISTED) (LMNL:DL)
8.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 26, 16:00
Liminal Biosciences 1 Year Total Returns (Daily)
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
September 26, 2023 | 87.60% |
September 25, 2023 | 88.89% |
September 22, 2023 | 89.68% |
September 21, 2023 | 87.86% |
September 20, 2023 | 87.80% |
September 19, 2023 | 87.80% |
September 18, 2023 | 76.50% |
September 15, 2023 | 84.13% |
September 14, 2023 | 76.25% |
September 13, 2023 | 83.45% |
September 12, 2023 | 77.99% |
September 11, 2023 | 75.21% |
September 08, 2023 | 71.84% |
September 07, 2023 | 78.94% |
September 06, 2023 | 78.72% |
September 05, 2023 | 70.27% |
September 01, 2023 | 62.31% |
August 31, 2023 | 71.46% |
August 30, 2023 | 75.66% |
August 29, 2023 | 60.96% |
August 28, 2023 | 75.42% |
August 25, 2023 | 60.97% |
August 24, 2023 | 54.78% |
August 23, 2023 | 58.02% |
August 22, 2023 | 59.16% |
Date | Value |
---|---|
August 21, 2023 | 55.52% |
August 18, 2023 | 47.24% |
August 17, 2023 | 60.11% |
August 16, 2023 | 52.46% |
August 15, 2023 | 52.18% |
August 14, 2023 | 52.57% |
August 11, 2023 | 66.17% |
August 10, 2023 | 70.85% |
August 09, 2023 | 67.63% |
August 08, 2023 | 60.85% |
August 07, 2023 | 106.5% |
August 04, 2023 | 97.50% |
August 03, 2023 | 103.6% |
August 02, 2023 | 98.81% |
August 01, 2023 | 99.29% |
July 31, 2023 | 101.7% |
July 28, 2023 | 101.7% |
July 27, 2023 | 95.80% |
July 26, 2023 | 101.7% |
July 25, 2023 | 95.83% |
July 24, 2023 | 94.65% |
July 21, 2023 | 44.31% |
July 20, 2023 | 49.29% |
July 19, 2023 | 51.07% |
July 18, 2023 | 50.71% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.84%
Minimum
Aug 14 2019
200.9%
Maximum
Aug 14 2020
-54.52%
Average
-72.71%
Median
May 28 2020
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 10.17% |
Aurinia Pharmaceuticals Inc | -56.37% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |